Morgan Stanley
AFMD

Morgan Stanley’s Affimed AFMD Stock Holding History

Morgan Stanley’s Portfolio AFMD Stock Details AFMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-34,420
Closed -$24.9K – 8093
2025
Q1 		$24.9K Sell
34,420
-7,800
-18% -$7.96K ﹤0.01% 6488
2024
Q4 		$50.2K Sell
42,220
-180,201
-81% -$504K ﹤0.01% 6288
2024
Q3 		$747K Sell
222,421
-57,382
-21% -$253K ﹤0.01% 5209
2024
Q2 		$1.52M Buy
279,803
+152,853
+120% +$858K ﹤0.01% 4728
2024
Q1 		$673K Sell
126,950
-159,581
-56% -$909K ﹤0.01% 5175
2023
Q4 		$1.79M Buy
286,531
+181,402
+173% +$753K ﹤0.01% 4982
2023
Q3 		$502K Buy
105,129
+32,404
+45% +$179K ﹤0.01% 5169
2023
Q2 		$435K Buy
72,725
+17,192
+31% +$138K ﹤0.01% 5288
2023
Q1 		$414K Sell
55,533
-155,414
-74% -$1.55M ﹤0.01% 5360
2022
Q4 		$2.62M Buy
210,947
+163,558
+345% +$2.87M ﹤0.01% 4282
2022
Q3 		$976K Sell
47,389
-2,048
-4% -$56.9K ﹤0.01% 4896
2022
Q2 		$1.37M Buy
49,437
+34,007
+220% +$1.16M ﹤0.01% 4807
2022
Q1 		$674K Sell
15,430
-11,274
-42% -$490K ﹤0.01% 5222
2021
Q4 		$1.47M Sell
26,704
-57,226
-68% -$3.54M ﹤0.01% 4803
2021
Q3 		$5.19M Sell
83,930
-6,219
-7% -$409K ﹤0.01% 3652
2021
Q2 		$7.66M Sell
90,149
-262,113
-74% -$23.9M ﹤0.01% 3298
2021
Q1 		$27.9M Sell
352,262
-113,088
-24% -$7.34M ﹤0.01% 1618
2020
Q4 		$27.1M Buy
465,350
+355,426
+323% +$16.7M ﹤0.01% 1542
2020
Q3 		$3.73M Sell
109,924
-153,794
-58% -$5.82M ﹤0.01% 3006
2020
Q2 		$12.2M Buy
263,718
+253,149
+2,395% +$7.04M ﹤0.01% 1795
2020
Q1 		$167K Buy
10,569
+698
+7% +$16.6K ﹤0.01% 4947
2019
Q4 		$270K Buy
9,871
+6,995
+243% +$187K ﹤0.01% 5281
2019
Q3 		$85K Buy
2,876
+1,467
+104% +$43.6K ﹤0.01% 5497
2019
Q2 		$41K Buy
1,409
+112
+9% +$3.77K ﹤0.01% 5685
2019
Q1 		$54K Sell
1,297
-112
-8% -$4.03K ﹤0.01% 5628
2018
Q4 		$44K Sell
1,409
-39,498
-97% -$1.47M ﹤0.01% 5785
2018
Q3 		$1.78M Sell
40,907
-1,197
-3% -$33.9K ﹤0.01% 4091
2018
Q2 		$695K Buy
42,104
+9,397
+29% +$198K ﹤0.01% 4874
2018
Q1 		$605K Buy
32,707
+17,388
+114% +$328K ﹤0.01% 4889
2017
Q4 		$199K Buy
+15,319
New +$291K ﹤0.01% 5407
2017
Q3 		– Sell
-10
Closed – – 6523
2017
Q2 		$0 Hold
10
– – ﹤0.01% 6579
2017
Q1 		$0 Hold
10
– – ﹤0.01% 6566
2016
Q4 		$0 Sell
10
-4,785
-100% -$103K ﹤0.01% 6517
2016
Q3 		$133K Buy
4,795
+4,116
+606% +$115K ﹤0.01% 5195
2016
Q2 		$17K Buy
679
+584
+615% +$21.4K ﹤0.01% 5899
2016
Q1 		$4K Sell
95
-52
-35% -$1.96K ﹤0.01% 6311
2015
Q4 		$10K Sell
147
-383
-72% -$26K ﹤0.01% 6235
2015
Q3 		$33K Buy
530
+509
+2,424% +$63K ﹤0.01% 5876
2015
Q2 		$3K Buy
+21
New +$2.02K ﹤0.01% 6463
2014
Q4 		– Sell
-24
Closed -$1K – 6555
2014
Q3 		$1K Buy
+24
New +$1.5K ﹤0.01% 6483

Other funds holding AFMD

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Morgan Stanley's AFMD Position: Q2 2025 in Review

Morgan Stanley sold out of Affimed (AFMD) in Q2 2025, closing a stake of 34,420 shares — an estimated $24.9K sold.

Morgan Stanley first reported a position in AFMD in Q3 2014 and held it in 40 quarters. The position peaked at $27.9M in Q1 2021. 3 funds tracked by Wall St. Rank hold AFMD as of Q2 2025.

  • Morgan Stanley reported no remaining Affimed position as of Q2 2025 after selling out during the quarter.
  • Morgan Stanley sold 34,420 Affimed shares in Q2 2025, an estimated $24.9K.
  • Morgan Stanley first reported a position in Affimed in Q3 2014 and held it in 40 quarters.
  • Morgan Stanley's Affimed position peaked at $27.9M in Q1 2021.
  • 3 funds tracked by Wall St. Rank held Affimed as of Q2 2025.

Based on Morgan Stanley's 13F filing for Q2 2025, filed 15 Aug 2025.